AVI IBD PLUS

Dosage

Children: Refer to specific veterinary guidelines or pharmacological references for dosing information, as it varies widely based on the specific drug and condition being treated.

Adults: Refer to specific veterinary guidelines or pharmacological references for dosing information, as it varies widely based on the specific drug and condition being treated.

Mechanism of action

The mechanism of action for avian-related treatments varies widely depending on the specific substance or medication being used. For example, antiviral medications targeting avian influenza viruses may inhibit viral replication by interfering with the viral life cycle, often through mechanisms such as blocking viral entry into host cells or inhibiting viral neuraminidase activity.

Pharmacodynamics

Pharmacodynamics for avian-targeting drugs can include effects on avian physiology, such as modulation of immune response, reduction of viral load, or treatment of bacterial infections. The efficacy and effects depend on the specific condition being treated and the drug's pharmacological profile.

Pharmacokinetics

Pharmacokinetics will differ based on the specific substance being referenced. Typically, this includes absorption, distribution, metabolism, and excretion profiles that are unique to the drug class. In avian species, factors such as species-specific metabolism and physiological differences play crucial roles in how drugs are processed.

Pregnancy

Not enough data available regarding safety in pregnancy. Use with caution and only if the benefits outweigh the risks.

Breast-feeding

Limited data available. Consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Bursitis
• Tendinitis
• Osteoarthritis
• Rheumatoid arthritis
• Post-operative inflammation
• Other inflammatory joint conditions

Dosage

Children: Refer to the BNF for Children for appropriate dosing information based on age and condition.

Adults: Refer to specific BNF guidelines for dosing as it varies by the condition and the specific agent used.

Mechanism of action

The mechanism of action for agents indicated for bursal inflammation typically involves the modulation of immune response and reduction of inflammatory processes. This can include inhibition of pro-inflammatory cytokines, suppression of immune cell activation, or enhancement of anti-inflammatory mediators. Specific pathways may involve the NF-kB signaling pathway, phospholipase A2 inhibition, and modulation of arachidonic acid metabolism.

Pharmacodynamics

Pharmacodynamics for drugs affecting bursal conditions often includes the reduction of pain and swelling, improved mobility, and overall enhancement of joint function. The efficacy of these agents can be measured through clinical outcomes such as pain scales, range of motion assessments, and patient-reported symptom relief.

Pharmacokinetics

Pharmacokinetics of bursal-related therapies may vary widely depending on the specific drug class being considered. Generally, these agents may be administered orally or parenterally, with absorption rates and bioavailability influenced by formulation and route of administration. Metabolism typically occurs in the liver, and elimination can occur via renal pathways or through fecal excretion, depending on the molecular structure of the drug.

Pregnancy

There is limited information regarding the safety of bursal in pregnancy. It is advisable to avoid use unless the benefits outweigh the risks.

Breast-feeding

The excretion of bursal in human milk is unknown. Caution is recommended when administering to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Dosage

Children: Refer to specific medications used to treat the particular disease for dosing information.

Adults: Refer to specific medications used to treat the particular disease for dosing information.

Mechanism of action

The mechanism of action varies significantly depending on the specific disease in question. For infectious diseases, pathogens may interact with host cells, leading to inflammation, immune response activation, or tissue damage. Chronic diseases often involve complex interactions between genetic factors, lifestyle choices, and environmental influences. For example, in autoimmune diseases, the immune system mistakenly targets healthy cells, leading to inflammation and tissue destruction.

Pharmacodynamics

Pharmacodynamics of disease involves understanding how the disease state affects physiological functions and the body's response to treatment. In infectious diseases, the presence of pathogens can lead to altered immune responses, while chronic diseases may involve changes in metabolic pathways, hormonal balances, or cellular functions. Medications targeting disease processes aim to restore normal function, alleviate symptoms, or eradicate pathogens.

Pharmacokinetics

Pharmacokinetics is not applicable to the term 'disease' as it refers to the movement of drugs within the body, including absorption, distribution, metabolism, and excretion of specific medications used to treat diseases. Each medication will have its own pharmacokinetic profile depending on its chemical properties and the disease being treated.

Indications

• Bacterial infections
• Viral infections
• Fungal infections
• Parasitic infections
• Sepsis
• Pneumonia
• Urinary tract infections
• Skin and soft tissue infections

Dosage

Children: Refer to specific drug monographs for dosing information based on the type of infection and child's age and weight.

Adults: Refer to specific drug monographs for dosing information based on the type of infection and pathogen involved.

Mechanism of action

The mechanism of action of antimicrobial agents varies widely depending on the class of drug. For example, antibiotics may inhibit cell wall synthesis, protein synthesis, or nucleic acid synthesis in bacteria. Antivirals often target viral replication processes, while antifungal agents disrupt cell membrane integrity or inhibit essential metabolic pathways in fungi.

Pharmacodynamics

Pharmacodynamics of infectious disease treatments involves understanding the drug's effects on the pathogen, including the minimum inhibitory concentration (MIC) that inhibits bacterial growth, or the time and concentration needed to effectively reduce viral load. The efficacy of the antimicrobial therapy is influenced by factors such as the site of infection, the immune response of the host, and the susceptibility profile of the pathogen.

Pharmacokinetics

Pharmacokinetics of antimicrobial agents encompasses absorption, distribution, metabolism, and excretion. For instance, antibiotics may be well absorbed orally but have variable bioavailability. Distribution can be affected by tissue permeability and protein binding. Metabolism may occur in the liver, and excretion is primarily renal, influencing dosing in patients with renal impairment.

Pregnancy

Consult healthcare professional; safety varies by specific infectious agent and treatment.

Breast-feeding

Consult healthcare professional; safety varies by specific infectious agent and treatment.

Storage

Store in a cool, dry place, away from direct sunlight; specific storage may vary by formulation.

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Influenza
• HIV/AIDS
• Hepatitis B and C
• Herpes simplex virus infections
• Cytomegalovirus infections
• COVID-19
• Respiratory syncytial virus infections

Dosage

Children: Refer to specific antiviral agents for dosing guidance.

Adults: Refer to specific antiviral agents for dosing guidance.

Mechanism of action

Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.

Pharmacodynamics

The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.

Pharmacokinetics

Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.

Dosage

Children: Refer to the specific product label or clinical guidelines for dosing information.

Adults: Refer to the specific product label or clinical guidelines for dosing information.